Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Study of the Immunogenicity and Efficacy of HBsAg Vaccine in combination with standard antiviral therapy in patients who have been treated with HB110E Hepatitis B DNA vaccine

Trial Profile

Study of the Immunogenicity and Efficacy of HBsAg Vaccine in combination with standard antiviral therapy in patients who have been treated with HB110E Hepatitis B DNA vaccine

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Jun 2014

At a glance

  • Drugs GX 110 (Primary) ; Entecavir
  • Indications Hepatitis B
  • Focus Pharmacodynamics
  • Sponsors Genexine
  • Most Recent Events

    • 03 Jan 2014 Status changed from active, no longer recruiting to completed, as per ClinicalTrials.gov. record
    • 20 Jun 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 08 May 2013 New source identified and integrated (Clinical Research Information Service (CriS) - Republic of Korea: KCT0000713)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top